| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Mar 6, 2024 | Sarepta Therapeutics, Inc. | Director | Sell | 20.0 | -3,135 | -32.13% | ✗ | $385.5K |
| Aug 7, 2023 | Aug 9, 2023 | Allogene Therapeutics, Inc. | Director | Sell | 26.3 | -10,000 | -28.31% | ✗ | $42.9K |
| Nov 17, 2022 | Nov 21, 2022 | Sarepta Therapeutics, Inc. | Director | Sell | 22.5 | -858 | -11.84% | ✗ | $94.3K |